PPARGC1A and Parkinson disease: In contrast to the hypermethylated PGC-1α promoter (Su et al., 2015), they found the CpG-1 and CpG-2 islands of PARK7 to be unmethylated in both PD and the negative control group (Tan Y. et al., 2016).